0000950170-24-077487.txt : 20240625
0000950170-24-077487.hdr.sgml : 20240625
20240625182123
ACCESSION NUMBER: 0000950170-24-077487
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240621
FILED AS OF DATE: 20240625
DATE AS OF CHANGE: 20240625
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lewicki John A.
CENTRAL INDEX KEY: 0001553352
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38452
FILM NUMBER: 241070176
MAIL ADDRESS:
STREET 1: C/O ONCOMED PHARMACEUTICALS, INC.
STREET 2: 800 CHESAPEAKE DRIVE
CITY: REDWOOD CITY
STATE: MA
ZIP: 94063
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Mereo BioPharma Group plc
CENTRAL INDEX KEY: 0001719714
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: X0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE CAVENDISH PLACE
STREET 2: FOURTH FLOOR
CITY: LONDON
STATE: X0
ZIP: W1G0QF
BUSINESS PHONE: 4403330237300
MAIL ADDRESS:
STREET 1: ONE CAVENDISH PLACE
STREET 2: FOURTH FLOOR
CITY: LONDON
STATE: X0
ZIP: W1G0QF
FORMER COMPANY:
FORMER CONFORMED NAME: Mereo Biopharma Group plc
DATE OF NAME CHANGE: 20171016
4
1
ownership.xml
4
X0508
4
2024-06-21
0001719714
Mereo BioPharma Group plc
MREO
0001553352
Lewicki John A.
C/O MEREO BIOPHARMA GROUP PLC
4TH FLOOR, ONE CAVENDISH PLACE
LONDON
X0
W1G 0QF
UNITED KINGDOM
false
true
false
false
Chief Scientific Officer
false
American Depositary Shares representing Ordinary Shares
2024-06-21
4
M
false
69000
0
A
73003
D
American Depositary Shares representing Ordinary Shares
14196
I
By The Lewicki Family Living Trust dated December 6, 2000
Performance Based Restricted Stock Unit
0
2024-06-21
4
M
false
69000
0
A
2024-06-21
2025-01-25
American Depository Shares
69000
46000
D
Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer.
Represents performance-based restricted stock unit ("PSU") earned under the issuer's 2019 Employee Incentive Plan (the "Plan") that vested on June 21, 2024 based on satisfaction of ADS price threshold values over a two year performance period (expiring on January 1, 2025).
/s/ Christine Fox, by power of attorney
2024-06-25